Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Big Pharma
Licensing of COVID-19 treatments has shifted to include other medicines and treatment areas | World’s largest pharma companies still “consistently overlook the poorest countries” | Report offers strategy to improve access.   16 November 2022
Big Pharma
Firms aim to form a UPC litigation alliance | New court has significant implications for life sciences | UPC faces calls for delay over concerns regarding its case management system.   15 November 2022
Americas
Jazz accused a rival of infringement | Avadel filed a counterclaim seeking to delist the patent from the Orange Book.   15 November 2022
Biotechnology
What does it mean for women to be at the heart of our business? Janine Swarbrick and Sofie McPherson of HGF examine the gender balance in IP and what is being done to improve it.   15 November 2022
article
Case concerns epilepsy drug patent and medical cannabis R&D collaboration | Dispute between Japanese and Irish pharma firms will be heard in London due to arbitration carve-out clause.   10 November 2022
Big Pharma
Dispute over patent relating to a CAR-T cell therapy shunned by top court | Backing from Amgen, GSK and St. Jude's Children's Research Hospital over “exceedingly narrow” patent protection fails to convince Justices.   10 November 2022
article
WIPR Diversity sat down with Kathi Vidal, director of the US Patent and Trademark Office, to talk about her bold plans to encourage more women into the field of patents, expand the bar and make the agency a great place to work.   8 November 2022
article
Spruson & Ferguson has hired litigator Katrina Crooks as a principal, who will join its office in Sydney.   8 November 2022
article
Humanitarian organisations censure leaked IP provisions within UK-India free trade agreement | “Excessive measures” would “drastically harm access” to affordable, lifesaving generic medicines from India.   8 November 2022
Americas
The dispute centres on a section of the Patent Act concerning 'enablement' | The US government had urged the court to deny the petition.   7 November 2022